On April 7, 2009, Asahi Kasei and Misuzu & Sun Medical Holding (MSHD) reached a basic agreement for the joint development of business in all territories throughout the world outside Japan for the EVAHEART implantable Left Ventricular Assist System (LVAS) of Sun Medical Technology Research Corp. (Sun Medical), wholly owned subsidiary of MSHD.

Asahi Kasei Corporation is a selectively diversified enterprise group centered in chemicals, with business segments that include chemicals, housing, Pharmaceuticals and medical devices, fibers, electronics, materials and devices, construction materials and Engineering services. With head offices in Tokyo and Osaka, the company has locations worldwide including America, China, Europe, Hong Kong, Indonesia, Korea, Japan, Singapore, Taiwan and Thailand. For additional information, go to their website.